|
TAS::75 0849::TAS ADMINISTRATIVE MODIFICATION
|
261200800001E
|
$313,286,406
|
$256
|
DMITROVSKY, ETHAN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Childhood Cancer Survivor Study
|
5U24CA055727-24
|
$4,218,764
|
$843,753
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant (CCSG)
|
5P30CA030199-36
|
$3,887,448
|
|
POWIS, GARTH
|
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST
|
|
Understanding Ethnic Differences in Cancer: The Multiethnic Cohort Study
|
2U01CA164973-06
|
$3,176,130
|
|
LE MARCHAND, LOIC
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Cancer Center Support Grant
|
5P30CA014195-44
|
$3,092,538
|
|
SHAW, REUBEN
|
SALK INSTITUTE FOR BIOLOGICAL STUDIES
|
|
Program Project in Models of Breast Cancer
|
5P01CA094060-14
|
$2,620,541
|
|
NORTON, LARRY
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AID
|
ZIA SC 004020
|
$2,592,300
|
|
Berzofsky, Jay
|
CCR (NCI)
|
|
PDX Trial Center for Breast Cancer Therapy
|
1U54CA224076-01
|
$2,482,191
|
|
WELM, ALANA
|
UNIVERSITY OF UTAH
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144-07130
|
$2,383,555
|
|
Alter, Blanche
|
DCEG (NCI)
|
|
Mayo Clinic SPORE in Pancreatic Cancer
|
5P50CA102701-14
|
$2,300,000
|
|
PETERSEN, GLORIA
|
MAYO CLINIC ROCHESTER
|
|
UCLA SPORE in Prostate Cancer
|
5P50CA092131-15
|
$2,300,000
|
|
REITER, ROBERT
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
SPORE in Breast Cancer
|
5P50CA098131-16
|
$2,300,000
|
|
PIETENPOL, JENNIFER
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
The Ohio State University and MD Anderson Cancer Center Thyroid Cancer SPORE
|
5P50CA168505-05
|
$2,278,318
|
|
RINGEL, MATTHEW
|
OHIO STATE UNIVERSITY
|
|
Cold Spring Harbor Laboratory Cancer Research Center
|
3P01CA013106-45S1
|
$2,165,000
|
|
STILLMAN, BRUCE
|
COLD SPRING HARBOR LABORATORY
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-04S1
|
$2,088,480
|
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Hematopoietic Chimerism after Stem Cell Allografts
|
5P01CA078902-19
|
$2,023,730
|
|
STORB, RAINER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Head and Neck Cancer SPORE
|
5P50CA097190-13
|
$1,943,901
|
|
FERRIS, ROBERT
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens
|
1U01CA224146-01
|
$1,845,039
|
|
HAHN, WILLIAM
|
DANA-FARBER CANCER INST
|
|
CDU-UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities
|
5U54CA143931-08
|
$1,808,575
|
|
VADGAMA, JAYDUTT
|
CHARLES R. DREW UNIVERSITY OF MED & SCI
|
|
Barrett's Esophagus: Predictors of Progression
|
5P01CA091955-14
|
$1,731,544
|
|
REID, BRIAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Optimizing Novel Immunotherapy Combinations Targeting the Tumor Microenvironment in Canine Spontaneous Osteosarcoma
|
1U01CA224182-01
|
$1,672,078
|
|
DOW, STEVEN
|
COLORADO STATE UNIVERSITY
|
|
Area B: Precise DCE-MRI Assessment of Brain Tumors
|
1R33CA225400-01
|
$1,561,994
|
|
NAYAK, KRISHNA
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,537,925
|
$61,517
|
Barr, Frederic
|
CCR (NCI)
|
|
Pediatric Phase 1/Pilot Consortium
|
3UM1CA097452-15S1
|
$1,530,543
|
|
WEIGEL, BRENDA
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Clinical evaluation of the novel, uni-directional, Pd-103 CivaSheet for Pancreatic Cancers
|
4R44CA210770-02
|
$1,464,585
|
|
PEREZ, KRISTY
|
CIVATECH ONCOLOGY, INC.
|
|
Growth Factor Imaging and Photoimmunotherapy
|
ZIA BC 010656
|
$1,464,417
|
|
Choyke, Peter
|
CCR (NCI)
|
|
Molecular Response and Imaging-based Combination Strategies for Optimal PDT
|
5P01CA084203-13
|
$1,421,276
|
|
HASAN, TAYYABA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
South Carolina Cancer Disparities Research Center (SC CaDRe)
|
1U54CA210963-01A1
|
$1,344,584
|
|
SALLEY, JUDITH
|
SOUTH CAROLINA STATE UNIVERSITY
|
|
South Carolina Cancer Disparities Research Center (SC CADRE)
|
1U54CA210962-01A1
|
$1,265,194
|
|
FORD, MARVELLA
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
AVGN7, a Novel Gene Therapeutic for Treating Cancer Cachexia
|
1R44CA221539-01
|
$1,206,955
|
|
RODGERS, BUEL
|
AAVOGEN, INC.
|
|
1/3: The Chicago Collaborative to Promote and Advance Cancer Health Equity
|
5U54CA203000-03
|
$1,192,293
|
|
SIMON, MELISSA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Targeted Therapy for Non Small Cell Lung Carcinoma: Human Phase 1 safety and dose escalation studies
|
2R44CA162629-02A1
|
$1,154,726
|
|
SERRERO, GINETTE
|
A AND G PHARMACEUTICAL, INC.
|
|
Consequences of chronic Interferon-gamma expression on the host
|
ZIA BC 009283
|
$1,117,083
|
$111,708
|
Young, Howard
|
CCR (NCI)
|
|
Risk Factors for Breast Cancer in Younger Nurses
|
5R01CA050385-28
|
$1,041,084
|
|
WILLETT, WALTER
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
|
Breast Cancer Locator
|
6R44CA210810-03
|
$1,031,728
|
|
KRISHNASWAMY, VENKATARAMANAN
|
CAIRNSURGICAL, INC.
|
|
A phase IIA trial for the safety and tolerability of CD24Fc in prophylaxis of graft vs host disease.
|
1R44CA221513-01
|
$1,017,478
|
|
DEVENPORT, MARTIN
|
ONCOIMMUNE, INC.
|
|
Cellular Interactions with Thrombospondin
|
ZIA SC 009172
|
$1,003,208
|
$50,160
|
Roberts, David
|
CCR (NCI)
|
|
Molecular MR Imaging of the Desmoplastic Response in Pancreatic Cancer
|
5R44CA200186-03
|
$1,002,483
|
|
HUMBLET, VALERIE
|
COLLAGEN MEDICAL, LLC
|
|
CD206 Targeted Therapy for Kaposi Sarcoma and Tumor Associated Macrophages
|
4R44CA206788-02
|
$939,552
|
|
COPE, FREDERICK
|
NAVIDEA BIOPHARMACEUTICALS, INC.
|
|
Surgery Branch Cell Prep Core
|
ZIC BC 010905
|
$933,290
|
|
Wunderlich, John
|
CCR (NCI)
|
|
Pediatric Oncology Branch Behavioral Science Core
|
ZID BC 011517
|
$895,830
|
|
Glod, John
|
CCR (NCI)
|
|
Molecular pathways and targeted therapies in human leukemia
|
1R35CA210065-01A1
|
$849,333
|
|
FERRANDO, ADOLFO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Role of inflammation, innate resistance, and immunity in carcinogenesis
|
ZIA BC 010793
|
$840,626
|
|
Trinchieri, Giorgio
|
CCR (NCI)
|
|
2/3: The Chicago Collaborative to Promote and Advance Cancer Health Equity
|
5U54CA202995-03
|
$820,604
|
|
CIECIERSKI, CHRISTINA
|
NORTHEASTERN ILLINOIS UNIVERSITY
|
|
Implementing Universal Lynch Syndrome Screening across Multiple Healthcare Systems: Identifying Strategies to Facilitate and Maintain Programs in Different Organizational Contexts
|
1R01CA211723-01A1
|
$807,436
|
|
RAHM, ALANNA
|
GEISINGER CLINIC
|
|
Inherited colorectal cancer risk variants: from association to biology
|
7R01CA143237-07
|
$800,500
|
|
CASEY, GRAHAM
|
UNIVERSITY OF VIRGINIA
|
|
Integrated Training in Cancer Model Systems
|
5T32CA009156-42
|
$789,141
|
|
PAGANO, JOSEPH
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Histone Methyltransferases as a Target for Lung Cancer Prevention
|
5R01CA183296-04
|
$778,686
|
|
BELINSKY, STEVEN
|
LOVELACE BIOMEDICAL & ENVIRONMENTAL RES
|
|
Informal caregiver burden in advanced cancer: Economic and health outcomes
|
5R01CA196576-03
|
$768,288
|
|
SIMINOFF, LAURA
|
TEMPLE UNIV OF THE COMMONWEALTH
|
|
Personalized precision dosing of biologic therapies in oncology
|
1R44CA217336-01A1
|
$759,813
|
|
MESSMER, BRADLEY
|
ABREOS BIOSCIENCES, INC.
|
Total relevant funding to Heart for this search: $1,345,151
|